We are live on ! Find out more
ACM

Athyrium Capital Management Portfolio holdings

AUM $8.69M
1-Year Est. Return 34.58%
This Fund
S&P 500
This Quarter Est. Return
-0.46%
1 Year Est. Return
-34.58%
3 Year Est. Return
-25.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$154M
AUM Growth
-$125M
Cap. Flow
-$252M
Cap. Flow %
-163.64%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
+$129M

Sector Composition

Rank Sector Weight
1 Healthcare 13.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVLP
1
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$8.18M 5.31%
14,600,444
– –
BIOR
2
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$6.52M 4.23%
169,448
– –
PBYI icon
3
Puma Biotechnology
PBYI
$398M
$6.33M 4.1%
1,792,114
– –
AMYT
4
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
– –
-8,857,268
Closed -$129M

Similar funds

BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
KIM
Kaizen Investment Management Singapore $6.23M AUM
RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
HVM
Harvest Volatility Management Norwalk, Connecticut $4.39M AUM 13.08% 1-Year Est. Return

Athyrium Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Athyrium Capital Management held 8 positions worth $154M, down 45% from $279M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Athyrium Capital Management withdrew a net $252M in Q2 2023, closing 1 position. Its most notable exit was Amryt Pharma plc American Depositary Shares, an estimated $129M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 56% a quarter earlier.

  • Athyrium Capital Management fully exited Amryt Pharma plc American Depositary Shares in Q2 2023, selling an estimated $129M.
  • Athyrium Capital Management's ten largest holdings make up 100% of its $154M portfolio in Q2 2023.
  • Athyrium Capital Management opened 0 new positions and closed 1 in Q2 2023.
  • Athyrium Capital Management's portfolio value fell 45% quarter-over-quarter to $154M.

Based on Athyrium Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.